Cargando…

Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients

BACKGROUND: Aliskiren was shown to increase adverse events in patients with diabetes and concomitant renin–angiotensin blockade. We aim to investigate the efficacy and safety of aliskiren in patients with diabetes and increased cardiovascular risk or established cardiovascular disease. METHODS: MEDL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Sean L, Roddick, Alistair J, Ayis, Salma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5600262/ https://www.ncbi.nlm.nih.gov/pubmed/28844155 http://dx.doi.org/10.1177/1479164117715854

Ejemplares similares

Effect of aliskiren on cardiovascular outcomes in patients with prehypertension: a meta-analysis of randomized controlled trials
por: Zhang, Jing-Tao, et al.
Publicado: (2015)

Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis
por: Fu, Shufang, et al.
Publicado: (2017)

Correction: Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis
por: Fu, Shufang, et al.
Publicado: (2018)

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction
por: Verdecchia, Paolo, et al.
Publicado: (2008)

Protective Effects of Nanoparticle-Loaded Aliskiren on Cardiovascular System in Spontaneously Hypertensive Rats
por: Pechanova, Olga, et al.
Publicado: (2019)

Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor
por: Ali, Ayad K
Publicado: (2011)

Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
por: Hudson, Jemma, et al.
Publicado: (2022)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008)

Mortality and Major Adverse Cardiovascular Events in Hospitalized Patients With Atrial Fibrillation With COVID-19
por: Wang, Lucas, et al.
Publicado: (2023)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease
por: Tessitore, Elena, et al.
Publicado: (2021)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Patient Selection for Pemafibrate Therapy to Prevent Adverse Cardiovascular Events
por: Izumida, Toshihide, et al.
Publicado: (2022)

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
por: McMurray, John J.V., et al.
Publicado: (2012)

OR25-5 Adverse Cardiovascular Events and Cause Mortality in Men During Testosterone Treatment: Individual Patient and Aggregate Data Meta-Analyses
por: Andersen, Marianne, et al.
Publicado: (2022)

The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients
por: Ayerbe, Luis, et al.
Publicado: (2020)

Association of sclerostin with cardiovascular events and mortality in dialysis patients
por: Zou, Yun, et al.
Publicado: (2020)

Peripheral Artery Disease Screening in the Community and 1-Year Mortality, Cardiovascular Events, and Adverse Limb Events
por: Smolderen, Kim G., et al.
Publicado: (2022)

Clinical outcomes of adverse cardiovascular events in patients with acute dapsone poisoning
por: Kang, Kyung Sik, et al.
Publicado: (2016)

Factors Associated with Adverse Cardiovascular Events in Cancer Patients Treated with Bevacizumab
por: Ngo, Doan T. M., et al.
Publicado: (2020)

Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study
por: Cardoso, Claudia R. L., et al.
Publicado: (2020)

Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis
por: Li, Lin, et al.
Publicado: (2015)

Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Sutanto, Andryanto, et al.
Publicado: (2021)

Major Adverse Cardiovascular Events and Mortality Prediction by Circulating GDF-15 in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Xie, Suyi, et al.
Publicado: (2022)

Aliskiren: An orally active renin inhibitor
por: Wal, Pranay, et al.
Publicado: (2011)

Aliskiren and the dual complement inhibition concept
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007)

395 Clinical Features of Dress Syndrome in 42 Patients
por: Park, Mi-Ran, et al.
Publicado: (2012)

Correction: Aquaro et al. Post-Mortem Cardiac Magnetic Resonance in Explanted Heart of Patients with Sudden Death. Int. J. Environ. Res. Public Health 2022, 19, 13395
por: Aquaro, Giovanni Donato, et al.
Publicado: (2023)

Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta‐Analysis of More Than 20 000 Patients
por: Totzeck, Matthias, et al.
Publicado: (2017)

Red Yeast Rice Preparations Reduce Mortality, Major Cardiovascular Adverse Events, and Risk Factors for Metabolic Syndrome: A Systematic Review and Meta−analysis
por: Yuan, Rong, et al.
Publicado: (2022)

Endothelial Dysfunction Is Associated With Major Adverse Cardiovascular Events in Peritoneal Dialysis Patients
por: Lee, Mi Jung, et al.
Publicado: (2014)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

Chemotherapy and adverse cardiovascular events in colorectal cancer patients undergoing surgical resection
por: Koo, Chieh Yang, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
por: Chitturi, Kalyan R., et al.
Publicado: (2019)

Long-term cardiovascular adverse events in very elderly COVID-19 patients
por: Karadavut, Serhat, et al.
Publicado: (2022)

Cardiovascular Adverse Events Associated with Monoclonal Antibody Products in Patients with COVID-19
por: Zou, Jingrui, et al.
Publicado: (2022)

Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection
por: Jiang, Joy, et al.
Publicado: (2023)

IMPACT OF VACCINATION ON MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS WITH COVID-19
por: Jiang, Joy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gtiflali5cfdvo5cb4of08tg0r